A Combined Marker of Inflammation in Individuals with Mania

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Dickerson, Faith ^a   Stallings, Cassie ^a   Origoni, Andrea ^a   Vaughan, Crystal ^a   Katsafanas, Emily ^a   Khushalani, Sunil ^a   Yolken, Robert ^b  

^a SHEPPARD PRATT HEALTH SYSTEM   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIADIN; MASON PFIZER MONKEY VIRUS PROTEIN 24; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MANIA; MASON PFIZER MONKEY VIRUS; ONSET AGE; PROGNOSIS; PSYCHOSIS; RECURRENT DISEASE; SCHIZOPHRENIA; SCORING SYSTEM; TOXOPLASMA GONDII;

ADULT; BIOLOGICAL MARKERS; BIPOLAR DISORDER; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED;

EID: 84883430922     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073520     Document Type: Article

References (22)

1. Gershon ES, Alliey-Rodriguez N, Liu C, (2011) After GWAS: searching for genetic risk for schizophrenia and bipolar disorder. The American Journal of Psychiatry 168: 253-256.
2. Potash JB, DePaulo JR Jr, (2000) Searching high and low: a review of the genetics of bipolar disorder. Bipolar Disorders 2: 8-26.
3. O'Brien SM, Scully P, Scott LV, Dinan TG, (2006) Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. Journal of Affective Disorders 90: 263-267.
4. Ortiz-Dominguez A, Hernandez ME, Berlanga C, Gutierrez-Mora D, Moreno J, et al. (2007) Immune variations in bipolar disorder: phasic differences. Bipolar Disorders 9: 596-602.
5. Liu HC, Yang YY, Chou YM, Chen KP, Shen WW, Leu SJ, (2004) Immunologic variables in acute mania of bipolar disorder. Journal of Neuroimmunology 150: 116-122.
6. Dickerson F, Stallings C, Origoni A, Boronow J, Yolken R, (2007) Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder. Progress in Neuro-psychopharmacology & Biological Psychiatry 31: 952-955.
7. Huang TL, Lin FC, (2007) High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar mania. Progress in Neuro-psychopharmacology & Biological Psychiatry 31: 370-372.
8. Remlinger-Molenda A, Wojciak P, Michalak M, Karczewski J, Rybakowski JK, (2012) Selected cytokine profiles during remission in bipolar patients. Neuropsychobiology 66: 193-198.
9. Dickerson F, Stallings C, Vaughan C, Origoni A, Khushalani S, et al. (2012) Antibodies to the glutamate receptor in mania. Bipolar Disorders 14: 547-553.
10. Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, et al. (2012) Markers of gluten sensitivity in acute mania: a longitudinal study. Psychiatry Research 196: 68-71.
11. Torrey EF, Bartko JJ, Yolken RH, (2012) Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophrenia Bulletin 38: 642-647.
12. Dickerson F, Lillehoj E, Stallings C, Wiley M, Origoni A, et al. (2012) Antibodies to retroviruses in recent onset psychosis and multi-episode schizophrenia. Schizophrenia Research 138: 198-205.
13. Perron H, Hamdani N, Faucard R, Lajnef M, Jamain S, et al. (2012) Molecular characteristics of Human Endogenous Retrovirus type-W in schizophrenia and bipolar disorder. Translational Psychiatry 2: e201.
14. First M, Gibbon M, Spitzer RL, Williams JBW (1998) Structured Clinical interview for DSM-IV Disorders- Non-Patient Edition. New York: Biometrics Research.
15. First M, Gibbon M, Spitzer RL, Williams JBW (1996) User's Guide for the SCID-I, Structured Clinical Interview for DSM IV Axis I Disorders. New York, NY: Biometrics Research.
16. Randolph C, Tierney MC, Mohr E, Chase TN, (1998) The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. Journal of Clinical and Experimental Neuropsychology 20: 310-319.
17. Kay SR, Fiszbein A, Opler LA, (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13: 261-276.
18. Young RC, Biggs JT, Ziegler VE, Meyer DA, (1978) A rating scale for mania: reliability, validity and sensitivity. The British Journal of Psychiatry 133: 429-435.
19. Hamilton M, (1967) Development of a rating scale for primary depressive illness. The British Journal of Social and Clinical Psychology 6: 278-296.
20. Dickerson F, Boronow J, Stallings C, Origoni A, Yolken R, (2007) Toxoplasma gondii in individuals with schizophrenia: association with clinical and demographic factors and with mortality. Schizophrenia Bulletin 33: 737-740.
21. Bandeen-Roche K, Walston JD, Huang Y, Semba RD, Ferrucci L, (2009) Measuring systemic inflammatory regulation in older adults: evidence and utility. Rejuvenation Research. 12: 403-410.
22. Diehl GE, Longman RS, Zhang JX, Breart B, Galan C, et al. (2013) Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX(3)CR1(hi) cells. Nature. 494: 116-120.